✦ LIBER ✦

Cytotoxicity evaluation of enzyme inhibitors and absorption enhancers in Caco-2 cells for oral delivery of salmon calcitonin

✍ Scribed by Rakhi B. Shah; Anitha Palamakula; Mansoor A. Khan

Publisher: John Wiley and Sons
Year: 2004
Tongue: English
Weight: 332 KB
Volume: 93
Category: Article
ISSN: 0022-3549
DOI: 10.1002/jps.20007

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Novel complexation hydrogels for oral pe

Novel complexation hydrogels for oral peptide delivery:In vitro evaluation of their cytocompatibility and insulin-transport enhancing effects using Caco-2 cell monolayers

✍ Ichikawa, Hideki ;Peppas, Nicholas A. 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 164 KB 👁 1 views

## Abstract Poly[methacrylic acid‐grafted‐poly(ethylene glycol)] [P(MAA‐__g__‐EG)] is a complexation hydrogel molecularly designed for oral peptide delivery. In this work, the cytotoxicity and insulin‐transport enhancing effect of P(MAA‐__g__‐EG) microparticles on intestinal epithelial cells were e

In vitro and In vivo evaluation of posit

In vitro and In vivo evaluation of positively charged liposaccharide derivatives as oral absorption enhancers for the delivery of anionic drugs

✍ Julie A. Bergeon; Zyta M. Ziora; Adel S. Abdelrahim; Niklas U. Pernevi; Anne R. 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 363 KB 👁 2 views

Oral delivery of hydrophilic, ionisable drugs remains a major challenge in drug development and a number of active pharmaceuticals fail to reach the market of oral drugs because of a lack of absorption and/or stability issues. One possible approach to improving the bioavailability of such drug candi

Preparation and evaluation of an oral de

Preparation and evaluation of an oral delivery system for time-dependent colon release of insulin and selected protease inhibitor and absorption enhancer compounds

✍ Maria Dorly Del Curto; Alessandra Maroni; Anastasia Foppoli; Lucia Zema; Andrea 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 249 KB

The aim of this work was to prepare and evaluate an oral dosage form intended for time-dependent colon delivery of insulin along with a selected protease inhibitor (camostat mesilate) and absorption enhancer (sodium glycocholate). A previously described release platform, which had proven potentially